JAK3 inhibitor VI is a mutant specific inhibitor for epidermal growth factor receptor with the gatekeeper mutation T790M.

Nishiya, Naoyuki; Sakamoto, Yasumitsu; Oku, Yusuke; Nonaka, Takamasa; Uehara, Yoshimasa

Nishiya, Naoyuki; Sakamoto, Yasumitsu; Oku, Yusuke; Nonaka, Takamasa; Uehara, Yoshimasa.

Afiliación

Nishiya N; Naoyuki Nishiya, Yusuke Oku, Yoshimasa Uehara, Department of Microbial Chemical Biology and Drug Discovery, Iwate Medical University School of Pharmacy, Yahaba, Iwate 028-3694, Japan.
Sakamoto Y; Naoyuki Nishiya, Yusuke Oku, Yoshimasa Uehara, Department of Microbial Chemical Biology and Drug Discovery, Iwate Medical University School of Pharmacy, Yahaba, Iwate 028-3694, Japan.
Oku Y; Naoyuki Nishiya, Yusuke Oku, Yoshimasa Uehara, Department of Microbial Chemical Biology and Drug Discovery, Iwate Medical University School of Pharmacy, Yahaba, Iwate 028-3694, Japan.
Nonaka T; Naoyuki Nishiya, Yusuke Oku, Yoshimasa Uehara, Department of Microbial Chemical Biology and Drug Discovery, Iwate Medical University School of Pharmacy, Yahaba, Iwate 028-3694, Japan.
Uehara Y; Naoyuki Nishiya, Yusuke Oku, Yoshimasa Uehara, Department of Microbial Chemical Biology and Drug Discovery, Iwate Medical University School of Pharmacy, Yahaba, Iwate 028-3694, Japan.

World J Biol Chem ; 6(4): 409-18, 2015 Nov 26.

Article en En | MEDLINE | ID: mdl-26629323

Palabras clave

Epidermal growth factor receptor; Gatekeeper mutation; Non-small cell lung cancers; Tyrosine kinase inhibitor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Biol Chem Año: 2015 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google